South & Central America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables,

South & Central America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology (Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR, and Others), Offerings (Reagents & Consumables, Instruments, and Software & Services), Application (Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point of Care Diagnostics, Environmental Application, and Others), and End User (Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others)

The South & Central America PCR technologies market is expected to grow from US$ 684.37 million in 2022 to US$ 1,193.04 million by 2030. It is estimated to record a CAGR of 7.2% from 2022 to 2030.

Advancements in PCR Technologies Fuel South & Central America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes.

A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

South & Central America PCR Technologies Market Overview

The South & Central America PCR technologies market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is estimated to hold the major share of the regional market during the forecast period. The increasing prevalence of cancer in Brazil drives the PCR technologies market growth in the country. Also, the aging population, increasing demand for advanced medical technologies, and the emerging biotech sector would create opportunities for the market in the coming years. Cancer is one of the major causes of mortality in Brazil. In the last few years, cancer cases have increased across the country. According to Revista Brasileira de Cancerologia, in 2023, Brazil had ~7.04 million new cancer cases. Further, PCR technologies are the major tools in the cancer diagnosis process; further technological advancements have enhanced the diagnosis. Also, the increasing incidences of yellow fever are a public health concern in Brazil. During the emerging coronavirus pandemic in Brazil, the country's Health Ministry issued around a third of the 22.9 million available RT-PCR test kits. The federal government had provided 6.43 million real-time PCR assays for detecting SARS-CoV-2 to states. Further, Brazil has several players that are involved in the manufacturing of PCR tests. Therefore, the above-mentioned factors will likely contribute to the market growth during the forecast period.

South & Central America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

South & Central America PCR Technologies Market Segmentation

The South & Central America PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the South & Central America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of South & Central America PCR technologies market in 2022.

In terms of offerings, the South & Central America PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of South & Central America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

Based on application, the South & Central America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of South & Central America PCR technologies market in 2022.

Based on end user, the South & Central America PCR technologies market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of South & Central America PCR technologies market in 2022.

By country, the South & Central America PCR technologies market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, and Ellume Ltd are some of the leading companies operating in the South & Central America PCR technologies market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America PCR technologies market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America PCR technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.